Decheng Capital LLC Aclaris Therapeutics, Inc. Transaction History
Decheng Capital LLC
- $466 Billion
- Q4 2024
A detailed history of Decheng Capital LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 2,266,667 shares of ACRS stock, worth $5.08 Million. This represents 1.21% of its overall portfolio holdings.
Number of Shares
2,266,667Holding current value
$5.08 Million% of portfolio
1.21%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$31.9 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$21.6 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$19.9 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$13.9 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$10.5 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $149M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...